Te Ahumairangi Investment Management Ltd
Position in GILD — Gilead Sciences, Inc.
CIK 1832237
WELLINGTON, Q2
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,182,574
-$347,746 QoQ
Shares Held
48,936
+4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#532
of 2,266 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. GILD ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,182,574 | 48,936 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,530,320 | 46,856 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,379,534 | 51,976 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,677,316 | 60,156 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,583,017 | 59,376 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,574,711 | 49,752 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,230,081 | 56,621 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,771,421 | 80,766 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $6,199,119 | 90,353 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,736,289 | 91,963 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,183,399 | 88,673 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,758,462 | 116,873 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,947,656 | 129,073 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,366,317 | 112,888 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,958,189 | 104,347 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,786,018 | 126,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,293,566 | 150,357 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $8,954,775 | 150,627 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,875,468 | 136,007 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,801,588 | 126,007 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,952,282 | 130,007 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,016,337 | 139,507 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,438,137 | 110,507 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,573,800 | 88,207 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||